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ABSTRACT: Online two-dimensional (2D) comprehensive
liquid chromatography (LC × LC) has become increasingly
popular. Most LC × LC separations employ one or more
detectors at the outlet of the second dimension, 2D, with very
short runs to avoid undersampling. We used six detectors,
including dual parallel mass spectrometry (LC1MS2), for
detection of the first dimension, 1D. We made an argentation
(silver-ion) UHPLC column from a strong cation exchange
column for 2D, coupled with UV and LC1MS2 detection.
LC1MS2 in 1D combined with LC1MS2 in 2D, plus five other
detectors, constituted LC2MS4 in a comprehensive LC1MS2
× LC1MS2 2D-LC separation. Electrospray ionization (ESI)
high resolution accurate mass (HRAM) mass spectrometry
(MS) and atmospheric pressure chemical ionization (APCI) MS were used in parallel for 1D detection, while atmospheric
pressure photoionization (APPI) MS and ESI-MS were used for detection of 2D. The LC1MS2 used for 1D allowed
quantification of triacylglycerol (TAG) molecular species of Parinari curatellifolia and other seed oils, while the 2D allowed
isomers of TAG containing 18:3 fatty acyl chains as well as TAG regioisomers to be separated and identified. The LC1MS2 in 1D
allowed identification of oxo-TAG species by HRAM MS and quantification of 806.3 ± 1.3 and 1101 ± 22 μg/g of α- and γ-
tocopherols, respectively, in P. curatellifolia by APCI-MS. It is now feasible to use silver-ion UHPLC as the 2D separation in LC ×
LC and to use multiple mass spectrometers across both dimensions to perform conventional quantitative analysis and to take
advantage of the newest LC × LC separation technology to identify isomers that are otherwise difficult to separate.
Numerous reviews of two-dimensional liquid chromatog-raphy (2D-LC) techniques have appeared in recent years,
with those covering basic theory and principles1−3 and
describing 2D-LC coupled to mass spectrometry4 (MS) being
especially useful for the work described herein. Excellent
chapters describing both theoretical and practical aspects with
citations for numerous reviews and applications in a wide range
of fields have recently appeared.5,6 Note that the nomenclature
of Marriott et al.7 and Schoenmakers et al.,8 as reflected in the
chapter by Stoll,6 is used here. Although the peak capacity in
LC × LC is theoretically multiplicative (the product of the 1D-
LC peak capacities) if the 2D separations are perfectly
orthogonal, but in practice the maximum theoretical peak
capacity is rarely achieved.6 Nevertheless, it is typically possible
to achieve a higher (often much higher) peak capacity by
employing 2D-LC rather than 1D-LC.
Conventional LC × LC is typically done by using a low flow
rate in the 1D, which is all directed to the 2D. The low flow rate
helps minimize solvent incompatibility with the 2D solvent
system and provides wider peaks to allow more fractions to be
taken across the 1D peaks, which minimizes undersampling and
limits the sample amount on the 2D column to facilitate peak
refocusing. 2D-LC often uses very high flow rates in the 2D to
provide very fast runs so that several 2D runs can be
accomplished over the width of a 1D peak to adequately
reconstruct the peak profile. As Davis, Stoll, and Carr9
discussed elsewhere, undersampling results when too few
samples are taken across a peak.
Mondello and co-workers10−12 have pioneered the use of
comprehensive LC × LC for triacylglycerols (TAG) using Ag-
ion chromatography, which does a partial separation into
groups by degree of unsaturation coupled to nonaqueous
reversed-phase (NARP) HPLC, which further separates into
distinct peaks by partition number (PN), where the PN = #
carbons − 2 × # double bonds. Their work included the use of
atmospheric pressure chemical ionization (APCI) MS for
detection. Others soon followed with solvent modifications,
etc., aimed at providing improved separations,13 and a variety of
lipid applications.14−18
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One thing that most methods for TAG analysis by 2D-LC
have in common is the use of silver-ion chromatography in the
1D, followed by NARP UHPLC in the 2D. This is due in large
part to the commercial availability of silver-ion HPLC columns
and the lack of availability of silver-ion UHPLC columns (and
even a dearth of strong cation exchange (SCX) UHPLC
columns from which to make silver-ion columns). Unfortu-
nately, Ag-ion HPLC produces clusters of peaks, with TAGs
having similar degrees of unsaturation appearing in only
partially resolved clusters. This puts a greater demand on the
2D NARP-UHPLC separation to resolve those clusters.
In contrast, we already had a NARP-HPLC separation19 that
we liked for 1D-LC and just wanted to use Ag-ion UHPLC to
tease apart a few remaining overlaps and separate isomers.
Therefore, we made our own silver-ion UHPLC column from
one of the few SCX columns available, which we loaded with
silver using an approach that differs from the classic approach
that is still commonly used.20 Our standard NARP-HPLC
method19 utilized a substantial amount of ACN, which caused a
lack of retention on the silver-ion UHPLC column. Thus, we
implemented a methanol/ethanol/dichloromethane (MeOH/
EtOH/DCM) gradient for NARP-HPLC that is compatible
with the Ag-ion second dimension. The resolution is not quite
as good as our standard MeOH/ACN/DCM method, but this
is compensated for by the separation in the 2D.
Due to our earlier interest in the α-eleostearic acid (α-EA)
(9Z,11E,13E-octadecatrienoic acid)-containing TAGs in the
seed oil of cherry (Prunus cerasus) pit oil (CPO), the new
approach was applied to the same CPO and to parinari (African
Mobola Plum, Parinari curatellifolia) seed oil (PSO) and wild
soybean (Glycine soja) oil (SBO). Primary emphasis is on PSO
because, in addition to general nutrition parameters21,22
(protein, fiber, moisture, ash, total fat), little more than the
fatty acid (FA) composition has been previously reported,21
with that being erroneous or incomplete, although some limited
data for related species are also reported. There has been
reference to α-EA in other parinari species,23−25 which
contributed to our interest in the samples reported here. We
also extend our previous approach19 beyond vitamin D analysis
to other fat-soluble vitamins, specifically tocopherols in all three
seed oils.
We report here the first demonstration of comprehensive
2D-LC with double dual parallel mass spectrometry. Two mass
spectrometers operated in APCI-MS and ESI-high resolution
accurate mass (HRAM)-MS modes as well as UV, a
fluorescence detector (FLD), corona charged aerosol detector
(CAD), and an evaporative light scattering detector (ELSD)
were used to monitor the first dimension, coupled with two
other mass spectrometers operated in atmospheric pressure
photoionization (APPI)-MS and ESI-MS modes plus UV, for a
comprehensive LC2MS4 (or LC1MS2 × LC1MS2) analysis.
This approach allowed the first report of the diacylglycerol
(DAG) and TAG composition of PSO, identification of a
previously unreported oxo-FA, and the first report and
quantification of tocopherols in PSO and improved analysis
of tocopherols in CPO. Results were supplemented and
confirmed by gas chromatography (GC) with a flame ionization
detector (FID) and GC-MS in electron impact (EI) and
chemical ionization (CI) modes.
■ EXPERIMENTAL SECTION
Due to the number of instruments used for LC2MS4, most
instrument details are provided in the Supporting Information.
Column Preparation. An Epic-SCX strong cation ex-
change (SCX) column, 100 × 2.1 mm, 3 μm particles
(#122191-ESCX), was obtained from ES Industries, Inc. An
old Constametric 4100 MS quaternary HPLC pump was used
to flush the SCX column with Millipore D.I. H2O for at least an
hour at 0.2 mL/min. Then, a 500 mL bottle of 1.0 M AgNO3
solution (Sigma-Aldrich) was fitted with a cap and line and fed
directly into the Y-fitting supplying the reciprocating pump
heads. Initially, the outlet of the column was sent to waste;
then, after ∼30 min, the outlet was directed back into the
AgNO3 bottle. The system was located in a room with subdued
light, and the bottle of AgNO3 was placed inside two closed
nested boxes to eliminate light exposure. The solution was
allowed to recycle through the column overnight at 0.2 mL/
min, which represented ∼450 column volumes over 13 h. Next,
the AgNO3 was removed, and the column was flushed with D.I.
H2O at 0.2 mL/min for at least an hour. Finally, the column
was flushed with MeOH at 0.2 mL/min for an hour, after which
it was ready for use.
2D-LC Instrumentation. An Agilent 1200 HPLC system
that employed two Inertsil ODS-2 columns in series, 250 × 4.6
mm, 5 μm particles, which has been described previously,19 was
used for the 1D separation. A fluorescence detector (FLD) was
added between the diode array detector (DAD) and flow
splitter since the earlier report. A splitting system controlled
flow to each detector based on the length and I.D. of the fused
silica capillary directed to each instrument. Full details of all
components are provided in the Supporting Information and
are depicted in Figure 1. In summary, the 1D was monitored
using detection by a DAD, the FLD, the CAD, the ELSD (data
not shown), a TSQ Vantage EMR mass spectrometer operated
in APCI-MS mode, and a Q Exactive HRAM instrument
operated in ESI-MS mode (with 20 mM NH4OCOH in ACN,
1:4, at 20 μL/min via syringe pump). One branch of the
splitter, having a flow rate of 53.67 μL/min, was directed to the
Agilent G1170A switching valve with two 100 μL sample loops
installed, producing a loop fill time of 1.86 min and modulation
time of 1.91 min. The switching valve served as the interface to
Figure 1. LC1MS4 configuration of instruments for comprehensive
LC1MS2 × LC1MS2 plus UV, FLD, CAD, and ELSD.
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an Agilent 1290 UHPLC system composed of a binary pump,
column oven with the Epic-SCX/Ag-ion column installed, and
DAD. Flow after the DAD no. 2 was directed to a single Valco
tee splitter, with the two branches going to a TSQ Quantum
Access Max mass spectrometer operated in APPI-MS mode
with acetone dopant supplied by a dual piston syringe pump at
50 μL/min and an LCQ Deca XP ion trap mass spectrometer
operated in ESI mode with 50 μL/min NH4OCOH via syringe
pump. Syringe pumps were AB140B/C dual piston syringe
pumps. Syringe pumps for ESI instruments were plumbed
through electronically controlled valves attached or built into
the instruments to flush deionized water (from old HPLC
pumps) through the sources between runs to reduce problems
with clogging. Control of all instruments was coordinated using
the 14-switch wireless communication contact closure system
(WCCCS) previously described.26 Visualization of the 2D-LC
chromatograms was done using LC Image v. 2.5b7 software
from GC Image, Inc.
GC Instrumentation. Analyses on an Agilent 6890N GC
with a FID and an Agilent 7890A GC with 5975C MS (in EI
and CI modes) were performed using the instruments and
conditions recently reported.27 Column and flow conditions are
given in the Supporting Information.
Quantification. Calibration levels of 0.125, 0.250, 0.500,
1.00, and 2.00 μg/mL were prepared from 25.0 μg/mL
(nominal) stock solutions of each fat-soluble vitamin (FSV)
listed below with each concentration adjusted for standard
purity (from Certificates of Analysis) and precise stock solution
concentration. d6-α-Tocopherol at 1.00 μg/mL was added as IS
to all standards and samples. Quantification of FSVs by MS was
done using APCI-MS in time-segmented selected ion
monitoring (SIM) and selected reaction monitoring (SRM)
modes using the parameters listed in the Supporting
Information. Quantification of DAGs and TAGs was done
using the GC-FID response-factor-adjusted approach previ-
ously described,28,29 with inclusion of 1×13C isotopic peaks for
added sensitivity without loss of specificity, as previously
discussed.30 Quantification of FSVs by UV detection was done
using wavelengths adapted from Ball,31 specifically 297 nm for
α-, γ-, and δ-tocopherols, 265 nm for vitamin D2 and D3, 326
nm for retinol (vitamin A), retinyl acetate, and retinyl
palmitate, and 248 nm for phylloquinone (vitamin K1).
Fluorescence detection of tocopherols was done using a legacy
detector (Agilent 1100 series) at 330 nm as a test of FLD
specificity. Additional parameters for UV and FLD are given in
the Supporting Information. All peaks were manually
integrated, and calculations were performed using the linest()
function in Excel spreadsheets using both IS and external
standard approaches (ES).19,30 Because the IS was optimized
for MS detection, results by UV could only be estimated as
discussed below.
■ RESULTS
We bypassed the problem of under-sampling and problems
associated with quantification of 2D-LC “blobs” by directly
monitoring the 1D using two mass spectrometers, operated in
APCI-MS and ESI-HRAM-MS modes as well as UV, FLD,
CAD, and ELSD. Chromatograms and calibration lines of α-
tocopherol by 1D SIM and SRM are shown in Figure 2.
Although we did not know to expect tocopherols in PSO, we
routinely run samples using our FSV and TAG screening
procedure, which allows quantification of any of the FSVs
mentioned above if they are present. Table 1 shows the results
for the IS approach by SIM and SRM APCI-MS in ppm or μg/
g of oil = mg/kg of oil with the first nonsignificant figure shown
or to 0.1. The coefficients of determination (r2) given in Table
1 indicate good linearity of the calibration lines. Results by the
ES approach by APCI-MS and the IS and ES approaches by UV
detection are given in the Supporting Information because
these are all less desirable and reliable than the IS approach by
MS. All ES and IS results by MS and UV, with the exception of
UV results for α-tocopherol in PSO, were in good to excellent
agreement among all approaches. To derive an estimation of IS
results by UV required approximation of the IS integrated areas
for 1.00 μg/mL as follows: the area for each α-tocopherol
calibration standard was divided by the α-tocopherol total
amount to give (area/(μg/mL)). Each area for all other FSVs
was divided by the same-run normalized IS area. For samples,
Figure 2. Chromatograms and calibration lines for α-tocopherol by
(A) selected ion monitoring and (B) selected reaction monitoring. FA
abbreviations: P, palmitic acid, 16:0 (carbons:double bonds); El, α-
eleostearic acid, 9c,11t,13t-18:3 (c = cis, t = trans); L, linoleic acid,
18:2; O, oleic acid, 18:1; S, stearic acid, 18:0; G, gadoleic acid, 20:1; A,
arachidic acid, 20:0.
Table 1. Quantification of α-, γ-, and δ-Tocopherols by SIM
and SRM APCI-MS in ppm (μg/g Oil)
Selected ion monitoring, internal standard method
α SD γ SD δ SD
cherry 293.5 3.5 630 26 97 14
parinari 789 28 881 45 6 16
soybean 29.9 0.3 168 14 227 13
r2 0.9996 0.9883 0.9917
Selected reaction monitoring, internal standard method
α SD γ SD δ SD
cherry 281 12 897.8 5.4 120.8 6.9
parinari 806.3 1.3 1101 22 34.0 6.3
soybean 18.9 0.2 193.0 1.4 198 13
r2 0.9988 0.9943 0.9956
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the average normalized signal area across all standards (=
5.5294 ± 0.6330) was used as the IS area because it was
unknown how much of the α-tocopherol was attributable to the
IS and how much came from the oil sample. Again, no such
approximation was required for results by ES or IS by MS or ES
by UV.
FAs, DAGs, and TAGs. The FA composition calculated
from the sum of response-factor-normalized DAGs and TAGs
and by GC-FID for FAs present at ≥0.1% for P. curatellifolia is
given in Table 2. Due to space limitations, all 18:3 species are
grouped together in Table 2, as are all oxo-18:3 FA. A more
detailed composition is provided in the Supporting Informa-
tion. As identified by GC-MS and quantified by GC-FID, 90.0
± 0.1% of 18:3 was α-eleostearic acid, 7.6 ± 0.1% was β-El, a
third isomer (unidentified) represented 1.7 ± 0.0%, and only
0.1 ± 0.0% was normal Ln, and these comprise almost all of the
48.8% in Table 2. While eleostearic acid has been reported
previously, this represents the first report of oxo-eleostearic acid
in P. curatellifolia. Four oxo-El isomers were found by GC-MS
and quantified by GC-FID, with the two major isomers
representing 81.0 ± 0.8% and 13.3 ± 0.3%, comprising the
majority of the 1.5% of oxo-El shown in Table 2. The
compositions of DAGs and TAGs are given for the first time in
Tables 3 and 4, respectively. DAGs represented only 1.52% of
the total area of DAGs and TAGs. Figure 3 shows an ESI-
HRAM-MS chromatogram and mass spectra of eleostearic acid
and two oxygen functional group containing TAGs, and Figure
4 shows the APCI-MS data acquired in parallel. The [M
+NH4]
+ and [M + H]+ ions for several TAGs had unexpected
masses that were 14 mass units higher than those of normal
eleostearic acid containing TAGs, with accompanying [DAG]+
fragments at m/z 609.450 ([ElEl + 14]+). This mass difference
could represent either a branched methyl-containing FA (−H +
CH3 = 14.0157) or an oxo-FA (−2H + O = 13.9793). Direct
detection by HRAM ESI-MS in the 1D allowed unambiguous
differentiation of these two possibilities. The mass accuracy for
normal, known TAGs were in the 2−4 ppm range, while for the
possible methylated TAGs, the mass differences were 42−45
ppm for the [M + NH4]
+ peaks and 62−63 ppm for the m/z
609.450 [DAG]+ fragment. On the other hand, the calculated
accurate masses for the oxo-eleostearic TAGs were within the
2−4 ppm range for all [M + NH4]+ and [DAG]+ fragments
(normal and ox-El), providing very strong evidence that the
unknown TAG molecular species contained oxo-eleostearic
acid. GC-MS chromatograms (not shown) exhibited a
corresponding peak at m/z 306.2 representing the oxo-18:3
FAME. Finally, the chromatographic behavior of oxo-TAGs,
which eluted prior to normal TAGs on the RP-HPLC column
due to increased polarity, is consistent with expected behavior
under RP-HPLC conditions. Several steps were taken to
confirm that the oxo-TAGs were endogenous native species
and were not formed during extraction. All data confirm the
identification of multiple DAG and TAG molecular species
containing oxo-eleostearic acid, shown in Tables 3 and 4, with
oxo-TAGs being 4.65% of the response-factor-normalized TAG
integrated area. The exact type and location of the oxo-
Table 2. FA Composition Calculated from DAG and TAG
Composition of P. cuatellifolia Compared to FA from GC-
FID of FA Methyl Esters
FA average (%) SD (%) GC-FID (%)
P 9.1 0.0 9.3
El 48.8 0.1 48.8
L 14.4 0.1 14.0
O 17.7 0.1 17.5
S 7.3 0.1 7.6
A 0.4 0.0 0.4
G 0.7 0.0 0.7
oxo-El 1.6 0.0 1.5
sum 99.9 99.9
Table 3. Response Factor Normalized DAG Composition for
P. curatellifolia
DAG RT (1)a % comp DAG pk. 2/1b
oxElEl 19.09 0.7 0.21
oxElL 21.09 0.1 0.28
oxElO 26.30 0.2 0.23
oxElP 26.59 0.1 0.30
ElEl 32.46 17.4 2.57
PoO 35.68 0.8 1.61
LEl 35.84 11.2 2.72
LL 37.60 11.7 4.19
OEl 39.02 12.5 1.57
OL 39.77 14.7 3.43
PL 39.96 6.8 1.53
OO 41.73 6.9 1.50
OP 42.00 7.0 0.72
SL 42.55 4.8 1.59
OS 44.99 5.1 0.52
sum 99.9%
aRetention time for first peak of the pair. bRatio of DAG peak 2 to
DAG peak 1.
Table 4. Response Factor Normalized TAG Composition for
P. curatellifolia
TAG RT % comp TAG RT % comp
oxElElEl 46.02 1.3 POL 75.30 2.1
oxElElL 47.08 0.4 LLS 76.15 0.5
oxElElO 50.54 0.9 PPL 77.15 0.7
oxElElP 51.23 0.7 LElA 79.48 0.3
oxElLO 51.87 0.1 ElElA 79.89 0.5
oxElOO 56.21 0.1 SOEl 82.19 3.0
oxElElS 56.26 0.9 OOO 82.21 1.0
oxElOP 56.83 0.1 OLG 82.29 0.3
oxElOS 63.36 0.1 OOP 84.24 1.4
ElElEl 55.11 12.0 ElSP 84.32 1.0
ElElL 56.70 8.3 PLG 84.37 0.2
LLEl 58.47 3.3 SLO 85.04 1.4
LLL 60.31 0.4 POP 86.29 0.5
ElElO 62.05 11.3 SLP 87.09 0.9
ElElP 63.23 8.1 OOG 90.98 0.1
OLEl 64.10 7.8 ElOA 91.46 0.1
PLEl 65.44 4.6 OOS 93.68 0.8
LLO 66.33 1.0 ElSS 93.83 0.9
LLP 67.64 0.9 POS 95.79 0.7
ElElG 68.65 1.3 PLA 96.36 0.1
ElElS 70.83 8.9 SSL 96.38 0.4
OOEl 70.94 4.2 PPS 99.31 0.1
POEl 72.50 3.0 POA 104.09 0.1
LLG 73.27 0.2 SSO 104.19 0.3
OOL 73.53 1.8 sum 99.3
PPEl 74.35 0.4 oxo-TAG 4.65
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functional group could not be determined from the mass
spectra alone. However, comparison of the MS/MS spectra
from ElElEl and oxElElEl in Figure 3 hint that the oxo-group is
not at the distal end of the FA chain, and differences in the m/z
105−111 (= C8Hx) and m/z 117−119 (= C9Hx) peaks indicate
the possibility that it is an 8,9-oxo group. Unfortunately, time,
resources, and stakeholder interest will not allow us to pursue
identification of the exact identity of this oxo-FA. The early
eluting peaks should be collected and subjected to IR and NMR
analysis. We will be happy to share all LC-MS data. Finally,
there was both HRAM ESI-MS ([M+NH4]
+= m/z 918.681
observed) and APCI-MS ([M + H]+= m/z 901.6 obs) evidence
for the dioxo TAG oxEloxElEl present at a very low level at
earlier retention time, which was not quantified.
The FA, DAG, and TAG compositions for cherry pit and
wild SBO are given in the Supporting Information because
these have been reported previously and were used for
verification of the new approach. All results for CPO are in
good agreement with the results reported recently using 1D
NARP-HPLC.27 The SBO FA, DAG, and TAG compositions
are similar to results reported elsewhere, although previous
reports focused primarily on Glycine max commercially
produced soybeans rather than the wild type.
Second-Dimension (2D) Data. A contour plot for P.
curatellifolia by silver-ion UHPLC with APPI-MS detection is
shown in Figure 5 and that by ESI-MS is shown in Figure 6.
Corresponding 3D plots are given in Figures 7 and 8. As usual,
ESI-MS exhibits sensitivity greater than that of either APCI-MS
or APPI-MS, giving larger peaks in Figures 6 and 8. No attempt
was made to quantify the DAGs and TAGs using the contour
plots because these are known to be problematic for
quantification,6,32−35 and very effective quantification using a
well-established approach was provided by the 1D APCI-MS
data. The 2D data were used only for qualitative analysis. The
silver-ion UHPLC column provided a separation based on the
well-known principles that have been described for argentation
chromatography in the past. Boryana Nikolova-Damyanova and
William W. Christie provide an excellent tutorial for argentation
chromatography at the Lipid Library (http://lipidlibrary.aocs.
org/content.cfm?ItemNumber=40341). Because cis double
bonds produce stronger complexes with silver ions than trans
double bonds,36 the UHPLC column described here very
effectively separated ElElEl containing all α-eleostearic acid
from ElElEl containing a β-eleostearic acid FA, as seen in
Figures 5 and 6. Thus, comprehensive NARP-HPLC × Ag-ion-
UHPLC appears to be well-suited for differentiating cis/trans
isomers in TAGs.
Also, the position of the unsaturated FAs in TAGs has a
primary influence on the retention on the Ag-ion UHPLC
column, with those in the outer positions, i.e. 1 and 3, having a
stronger effect on retention than those in the middle, sn-2,
position. For example, Figure 9 shows a 2D UHPLC ESI-MS
EIC for m/z 904.8, which represents multiple isobaric TAG
molecular species and their isomers.
First, this shows that most peaks eluted in single, unsplit
peaks, although some (e.g., OSO) straddled two modulation
periods separated by the modulation time, as shown for OSO in
Figure 9. This greatly simplified interpretation of data and gave
the sharp peaks exemplified in Figures 7 and 8. Second, the
silver-ion column readily differentiated between two oleic acid
chains in the 1,2 positions in OOS from two oleic chains in the
1,3 positions in OSO. However, because retention was based
on degree of unsaturation, with minimal effect of chain length,
OSO and GPO, which both have two monounsaturated FAs in
Figure 3. Q Exactive Orbitrap ESI-HRAM-MS total ion current chromatogram (TIC) and mass spectra for trieleostearin, ElElEl, and two TAGs
containing previously unidentified oxo-eleostearic acid, oxElElEl, and oxElElP (column 1); low-energy CID MS/MS of [M+NH4]
+ (column 2); and
higher-energy CID of m/z 595 or m/z 609 [DAG]+ fragment (column 3). FA abbreviations are in the Experimental Section.
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the 1,3 positions were not separated, although these could be
distinguished by the different [DAG]+ fragments despite having
one [DAG]+ fragment, m/z 605.5, and the protonated molecule
mass in common. Similarly, SLS was differentiated from SSL
due to the different position of the “L” FA. But SLS was not
separated from PLA, which has different saturated FA chain
lengths at 1 and 3, but the “L” FA in the same sn-2 position. In
general, the first row of TAGs eluted in Figures 5 and 6 had one
or no cis double bonds in one of the 1 or 3 positions with one
or no cis double bonds in the sn-2 position, with the exception
of oxo-El, in which the oxo- group appeared to reduce
coordination of El with the Ag+ and reduce retention (i.e.,
oxElElEl). The second row of TAGs had either two cis double
bonds in the 1 or 3 positions or one diunsaturated FA (i.e., “L”)
in the sn-2 position. Additional unsaturation in the 1,3 positions
had a greater influence on retention with additional
unsaturation in the sn-2 position having a slightly lesser effect
on retention, as mentioned above. Because APPI-MS and ESI-
MS were used for detection in the 2D, assignment of
regioisomer identities by the Critical Ratio37,38 [AA]+/[AB]+
by MS was less reliable38 than by APCI-MS. For instance, the
difference in [OO]+/[OS]+ between OOS sand OSO(2) in
Figure 9 is not as large as expected or reported using APCI-
MS.39 Fortunately, Ag-ion UHPLC was very effective for
separating regioisomers, reducing the need to rely on fragment
ratios in ESI-MS/MS or APPI-MS mass spectra.
■ DISCUSSION
Although complete details are not given, Powell40 described
producing a silver-ion column from a sulfonate derivatized silica
column by flowing silver nitrate through the column. Although
we were not initially aware of that work, we used a similar
approach, differing primarily in the fact that we employed
exhaustive saturation by recycling AgNO3 through a
commercially available SCX column overnight. Both ap-
proaches contrast the more commonly used approach by
Christie20 of manually injecting AgNO3 solution, which has
been widely used to good effect. In the first sequence of runs
immediately after preparation of a new column, small amounts
of silver adducts were formed during ESI-MS, but these quickly
disappeared with further use. No corrosive effects of AgNO3
elution were observed in the ionization source of any
instrument. This approach has been used both for 1.8 μm
particle and 3.0 μm particle columns, but we prefer the latter
for increased robustness.
It is important to emphasize that the excellent quantitative
results reported here would not be possible using conventional
comprehensive 2D-LC approaches. Quantification of 2D 2D-
LC data is an ongoing area of development,32 but is not yet as
straightforward as conventional integration of 1D or 1D
chromatograms. As mentioned by Place et al.,33 each 2D
peak consists of individual 1D chromatograms (slices) that
Figure 4. TSQ Vantage EMR APCI-MS TIC and mass spectra for ElElL, oxElElL, and oxElElO (column 1), low-energy CID MS/MS of [M + H]+
(column 2), and higher-energy CID of m/z 595 or m/z 609 [DAG]+ fragment (column 3). FA abbreviations are in the Experimental Section. See
Table 4 for TAG composition from APCI-MS.
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would normally be manually integrated in 1D analysis. But
having numerous slices across each 2D peak makes such
integration impractical. So, they described several approaches
for automated integration of 2D peaks, which involved lab-
written procedures in the R programming language. Cook et
al.34 discussed the several-fold higher %RSDs encountered in
2D-LC and the reasons for these and many other factors,
including the poorer S/N due to peak dilution caused by peak
fractionation. They employed a single UV detector at the outlet
of the 1D, for 2D assisted LC, or 2DALC. Recently, targeted
Figure 5. Second dimension silver-ion UHPLC separation with APPI-MS of P. curatellifolia seed oil.
Figure 6. Second dimension silver-ion UHPLC separation with ESI-MS of P. curatellifolia seed oil.
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quantitative MS analysis of two target compounds using
multiple reaction monitoring (MRM) was combined with
qualitative analysis of wine polyphenols.35 But because we
wanted to quantify multiple FSVs and semiquantify a large
number of DAGs and TAGs (by relative percentage
composition), we took an approach similar to 2DALC but
with many more detectors.
Quantification of CPO tocopherols was included because the
extract-and-shoot approach gave values that were substantially
higher than those values reported by a commercial lab in our
recent report. The results reported earlier were obtained using
the traditional approach to sterol analysis, involving heated
saponification, extraction, and collection of unsaponifiable
material and derivatization followed by GC-FID analysis. By
eliminating all harsh and inefficient treatment such as
saponification and derivatization, we observed higher levels.
Additional work is underway to confirm these results by
analysis of standard reference material 3278 from the National
Institute of Standards and Technology. Furthermore, the use of
both SIM and SRM (often thought of as the “gold standard” for
analysis) MS provided very strong confirmation of tocopherol
identity as well as quantity. Additionally, by obtaining survey
MS and data-dependent MS/MS scans on all instruments, we
are able to refute the presence of β-sitosterol that was reported
by the same commercial lab using the same saponification,
extraction and collection, and derivatization approach in CPO.
Using APCI-MS EICs for a 5 Da mass range including γ-
tocopherol (Table 1) ([M + H]+ = m/z 417.4) and β-sitosterol
([M + H]+ = m/z 415.4), we were able to clearly see the peaks
for γ-tocopherol but not β-sitosterol. This demonstrates that
peaks at a given retention time by GC without confirmation by
MS, especially after extensive chemical pretreatment, are not
sufficient for identification and quantification. Thus, it is
advisible to view commercial lab results that do not include MS
with healthy skepticism. Similar skepticism should be applied to
SIM versus SRM results. Any interfering species that produce
fragments or other ions similar to target compounds can skew
SIM results. SRM is a more selective process, providing a
higher degree of confidence. Nevertheless, because this
approach has not yet been validated using a standard reference
material (underway), these results for tocopherols are
preliminary results.
Skepticism was also applied to observation of the oxo-FA,
oxo-DAGs, and oxo-TAGs. To prove that these were not
produced by oxidation during the Folch extraction process, we
conducted experiments in which all solvents were deaerated
with argon, and extractions were done using both cold solvents
and room temperature solvents. The oxo-DAGs and oxo-TAGs
were present in all samples regardless of treatment. Thus, we
can conclude that these did contain uncommon oxo-FAs. We
doubt that these are hydroxyl-FAs because they lack the very
common dehydration products, −H2O = Δ18 Da, that appear
with large abundances in ESI-MS/MS and APCI-MS spectra of
hydroxyl-TAGs.41,42
It should be pointed out that the 2D solvent system (MeOH/
ACN) is entirely compatible and miscible with the 1D solvent
system (MeOH/EtOH/DCM), thereby eliminating all compat-
ibility issues that can arise using hexane-based solvent systems
for Ag-ion HPLC. Also, the column-switching valve was
plumbed in countercurrent mode (first in, last out) because
the polyunsaturated TAGs that eluted first in the 1D eluted last
in the 2D. Furthermore, cis-polyunsaturated DAGs and TAGs
did not elute from the Ag-ion UHPLC column until the ACN
content reached a sufficient level, so there was a degree of
sample reconcentration at the head of the column, contributing
to the sharp peaks seen in Figures 7 and 8.
When referring to the 1 and 3 positions of the glycerol
backbone, we no longer use the designation sn (stereospecific
numbering), because NARP HPLC, Ag-ion UHPLC, ESI-MS,
APCI-MS, and APPI-MS are not capable of distinguishing
enantiomers. The only position that can be known from these
data is the sn-2 position. Chiral chromatography is required to
differentiate the sn-1 and sn-3 positions. Therefore, the labels
for the 1 and 3 positions are interchangeable unless chiral
chromatography has been applied.
Figure 7. 3D plot of Ag-ion UHPLC APPI-MS for P. curatellifolia.
Figure 8. 3D plot of Ag-ion UHPLC ESI-MS for P. curatellifolia.
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An interesting observation that was unique to PSO was the
difference in the ratios of the intact DAG peaks shown in Table
3 (in the column labeled DAG pk. 2/1). In most seed oils, the
1,2 + 2,3-DAG peak elutes earlier and is ∼2 times larger than
the 1,3-DAG peak, which is smaller and elutes just after the
larger peak. In PSO, even normal DAGs like LL showed a larger
second peak as well as El-containing DAGs like ElEl and ElL
and oxo-DAGs, oxo-ElEl, oxo-ElL, etc.
Another interesting observation was that APCI-MS and MS/
MS spectra of di-El containing TAGs (ElElEl, ElElL, ElElO,
etc.) showed almost exclusively the [ElEl]+ [DAG]+, m/z 595.5,
with very little of the [ElX]+ [DAG]+ fragment. This unique
behavior may indicate the possibility of cross-linking of the di-
El FA chains during ionization in the APCI source, making it
energetically unfavorable for formation of the [ElX]+ fragment.
This possibility was also indicated by the appearance of more of
a m/z 593 fragment in ESI-MS/MS and APCI-MS mass spectra
(Figures 4 and 5) than is formed from normal LnLnLn, which
forms virtually only the expected m/z 595.5. Furthermore,
TAGs containing oxElEl behaved in a similar manner,
producing m/z 609.5 with little or no [ElL]+, [ElO]+, or
other related [DAG]+ fragments, as in Figure 4.
Finally, some readers may believe that this system of two
chromatographs with four mass spectrometers is prohibitively
complex or expensive and cannot readily be replicated. We
want to point out that researchers may take aspects of the
experiments that are needed and leave unnecessary parts
behind. If we had only one mass spectrometer for the 1D, we
would use the HRAM Q Exactive Orbitrap instrument in
APCI-MS mode. This would still allow identification of
unknowns by HRAM MS, while also allowing quantification
of FSVs, most of which do not respond well to ESI-MS without
derivatization. Some may not be interested in 2D-LC at all, but
the demonstration of Ag-ion UHPLC can be applied to
standalone UHPLC in new ways. This arrangement of
experiments was not expensive, because the slow 2D
chromatography and maintaining and repairing instruments
ourselves allows us to keep older, inexpensive instruments in
service, providing valuable data long after they have been
retired elsewhere. The WCCCS system was not at all expensive,
makes switching between instruments in experiments very easy,
and would be a valuable addition to any LC-MS lab. Thus,
while we demonstrated an unprecedented series of experiments
that employ a novel arrangement of instruments, many of the
components and concepts can be taken and applied individually
to address a wide variety of analytical problems.
■ CONCLUSIONS
This work represents the first report of an application
employing comprehensive 2D-LC with quadruple parallel
mass spectrometry, or LC1MS2 × LC1MS2, for an LC2MS4
approach. Also reported here are the first examples of
production of a silver-ion UHPLC column for triacylglycerol
analysis, Ag-ion UHPLC, and Ag-ion UHPLC used as the 2D in
comprehensive 2D-LC. This work provides the first description
of intact DAGs and TAGs from P. curatellifolia seed oil, of an
oxo-FA in P. curatellifolia along with its confirmation using
HRAM ESI-MS and GC-MS, and the first quantification of oxo-
DAGs and oxo-TAGs for PSO. APCI-MS data provided
indications of unique ionization and fragmentation mechanisms
occurring in the APCI source for TAGs containing conjugated
trans double bonds. This work provides the first quantification
Figure 9. Extracted ion chromatograms and mass spectra of m/z 904.8 by Ag-ion UHPLC ESI-MS and MS/MS showing differentiation of
regioisomers. DOP: dioctyl phthalate (plasticizer). FA abbreviations are in the Experimental Section.
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of tocopherols in P. curatellifolia and shows the benefit of an
extract-and-shoot approach for tocopherols in cherry pit oil.
Further, these experiments describe the use of slow
comprehensive 2D-LC, in which the problem of undersampling
is bypassed by direct detection using six detectors in the 1D.
This allowed more flexibility in 2D method development and
instruments to be used that were older than those in
conventional fast 2D-LC. The Ag-ion UHPLC column was
ideal for separation of TAGs by type of double bond (cis versus
trans) and of regioisomers based on the locations of
unsaturated FAs, either in the 1,3 positions or the sn-2
position. These experiments employed a unique wireless




The Supporting Information is available free of charge on the
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Experimental details for the Folch extraction, FAME
preparation, GC-FID, and GC-MS analysis conditions,
HPLC and UHPLC systems, and all mass spectrometers;
external standard results for tocopherols by APCI-MS
and internal standard and external standard results by UV
detection; detailed compositions of FAMEs, DAGs, and
TAGs for PSO, CPO, and SBO; and 2D UHPLC contour





William C. Byrdwell: 0000-0001-8241-428X
Notes
The author declares no competing financial interest.
■ ACKNOWLEDGMENTS
The work of Dr. Robert Goldschmidt to extract the oil and
perform the analysis of fatty acid methyl esters by GC-FID and
confirmation of identities by GC-MS is gratefully acknowl-
edged. The work of Mr. Lucas Stolp and Dr. Dharma Kodali to
provide the CPO sample is gratefully acknowledged. This work
was supported by the USDA Agricultural Research Service.
Mention or use of specific products or brands does not
represent or imply endorsement by the USDA.
■ REFERENCES
(1) Dugo, P.; Cacciola, F.; Kumm, T.; Dugo, G.; Mondello, L. J.
Chromatogr. A 2008, 1184, 353−368.
(2) Malerod, H.; Lundanes, E.; Greibrokk, T. Anal. Methods 2010, 2,
110−122.
(3) Bedani, F.; Schoenmakers, P. J.; Janssen, H. G. J. Sep. Sci. 2012,
35, 1697−1711.
(4) Donato, P.; Cacciola, F.; Tranchida, P. Q.; Dugo, P.; Mondello, L.
Mass Spectrom. Rev. 2012, 31, 523−559.
(5) Cacciola, F.; Donato, P.; Mondello, L.; Dugo, P. In Handbook of
Advanced Chromatography/Mass Spectrometry Techniques; Holcǎpek,
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Time (min)  %A (MeOH)  %B (ACN)  %C (EtOH)  %D (DCM) 
0.0  95.0  0.0  5.0  0.0 
25.0  95.0  0.0  5.0  0.0 
30.0  60.0  0.0  15.0  25.0 
40.0  65.0  0.0  10.0  25.0 
50.0  65.0  0.0  10.0  25.0 
51.0  95.0  0.0  5.0  0.0 
54.0  95.0  0.0  5.0  0.0 
2) Seed oil extracts: 
Table S‐2. 1D HPLC gradient for seed oil extracts. 
Time (min)  %A (MeOH)  %B (ACN)  %C (EtOH)  %D (DCM) 
0.0  95.0  0.0  5.0  0.0 
25.0  95.0  0.0  5.0  0.0 
30.0  60.0  0.0  15.0  25.0 
40.0  65.0  0.0  10.0  25.0 
50.0  65.0  0.0  10.0  25.0 
70.0  65.0  0.0  10.0  25.0 
90.0  50.0  0.0  25.0  25.0 
100.0  35.0  0.0  40.0  25.0 
110.0  30.0  0.0  45.0  25.0 
118.0  30.0  0.0  45.0  25.0 
120.0  95.0  0.0  5.0  0.0 




Wavelength (nm)  Bandwidth (nm) Reference nm  Reference nm  Analyte(s) 
210  5  360  100  Generic 
248  9  360  100  Phylloquinone (Vit. K1) 
265  9  360  100  Vitamin D2 & D3 
297  11  450  100  Tocopherols (Vit. E) 




















































1D Time (min)  0.00  0.55  1.5  1.70  1.80 
0.0  100.0  100.0  90.0  90.0  100.0 
40.0  100.0  100.0  90.0  90.0  100.0 
50.0  100.0  100.0  10.0  10.0  100.0 
60.0  100.0  100.0  35.0  35.0  100.0 
70.0  100.0  100.0  60.0  60.0  100.0 
120.0  100.0  100.0  90.0  90.0  100.0 









1D Time (min)  0.00  0.55  1.5  1.70  1.80 
0.0  100.0  100.0  90.0  90.0  100.0 
40.0  100.0  100.0  90.0  90.0  100.0 
50.0  100.0  100.0  10.0  10.0  100.0 
60.0  100.0  100.0  35.0  35.0  100.0 
70.0  100.0  100.0  60.0  60.0  100.0 
120.0  100.0  100.0  90.0  90.0  100.0 





1D Time (min)  0.00  0.55  1.5  1.70  1.80 
0.0  100.0  100.0  95.0  95.0  100.0 
40.0  100.0  100.0  95.0  95.0  100.0 
50.0  100.0  100.0  25.0  10.0  100.0 
60.0  100.0  100.0  40.0  35.0  100.0 
70.0  100.0  100.0  90.0  90.0  100.0 
120.0  100.0  100.0  95.0  95.0  100.0 





Wavelength (nm)  Bandwidth (nm)  Reference nm  Reference nm  Analyte 
210  5  360  100  Generic 
248  9  360  100  Phylloquinone (Vit. K1) 
265  9  360  100  Vitamin D2 & D3 
297  11  450  100  Tocopherols (Vit. E) 


























Parameter  Setting  Parameter  Setting 
Source parameters  See below  In‐source CID  0.0 eV 
Run time  54 min  Precursor resolution  140,000 
In‐source CID  45.0 eV  Product resolution  70,000 
Resolution  140,000  Precursor scan range  m/z 300‐750 
Scan range  m/z 200‐2000  Loop  Top 2 precursors 
AGC target  3e6  Isolation window  1.0 m/z 
Max. inj. time  200 ms  Norm. collision energy  50 
Mode   Centroid  Max. inj. time  Pre:100 ms/Prod:50 ms 




Parameter  Setting  Parameter  Setting 
Sheath gas (Nitrogen)  25  In‐source CID  0.0 eV 
Auxiliary gas (Nitrogen)  0  Resolution  Pre:140,000/Prod:70,000
Sweep gas  0  Precursor scan range  m/z 700‐1100 
Spray voltage  4000 V  Loop  Top 2 precursors 
Capillary temp.  250 oC  Isolation window  1.0 m/z 
Run time  130 min  Norm. collision energy  15 
In‐source CID  45.0 eV  DAG DDA MS/MS 
Resolution  140,000  In‐source CID  80.0 eV 
Scan range  m/z 200‐2000  Resolution  Pre:140,000/Prod:70,000
AGC target  3e6  Precursor scan range  m/z 350‐750 
Max. inj. time  200 ms  Loop  Top 3 precursors 
Mode   Centroid  Isolation window  1.0 m/z 























Scan range  m/z 200‐2000  403.358  ‐Tocopherol 
Scan time  1.8 s  416.365  ,‐Tocopherol [M]+∙ 
Scan events 2. & 3. DDA MS/MS  417.373  ,‐Tocopherol [M+H]+ 
Signal threshold  1e4  431.389  ‐Tocopherol 
Scan time  1.0 s  437.427  d6‐‐Tocopherol 
Collision energy  19 V  Scan event 4. Selected Reaction Monitoring (SRM) 
Repeat  Top 2 precursors  Scan time 0.5 s  Scan width 0.5  CID 19 V 
Segment 2 (2‐18 min)  Precursor (m/z) Product (m/z)  Analyte 
Scan event 1. Full‐scan MS same as Segment 1  385.347  367.337  Vitamin D3 
Scan event 2. 1 DDA MS/MS same as Segment 1  397.347  379.337  Vitamin D2 
Scan event 3. Q3 Selected Ion Monitoring (SIM)  403.358  137.122  ‐Tocopherol 
0.5 s scan time  0.5 scan width  416.365  151.133  ,‐Tocopherol 
m/z   Analyte  417.373  151.133  ,‐Tocopherol 
269.227  All retinols  431.389  165.149  ‐Tocopherol 




Scan time 0.5 s  Scan width 0.5  CID 19 V  Scan event 3. Q3 Selected Ion Monitoring (SIM) 
Precursor (m/z)  Product (m/z)  Analyte  0.5 s scan time  0.5 scan width 
269.227  93.070  Retinol  m/z   Analyte 
301.217  159.123  Retinoic Acid  451.358  Phylloquinone (Vit. K1) 
329.248  269.227  Ret. Acetate  473.400  ‐Tocopheryl Acetate 
Segment 3 (18‐36 min)  Scan event 4. Selected Reaction Monitoring (SRM) 
Scan event 1. Full‐scan MS same as Segment 1  Scan time 0.5 s  Scan width 0.5  CID 19 V 
Scan event 2. DDA MS/MS same as Segment 1  Precursor (m/z) Product (m/z)  Analyte 
Scan event 3. Q3 Selected Ion Monitoring (SIM)  451.358  187.240  Vitamin K1 

















































Scan range  m/z 150‐2000  Signal threshold  1e4 





















Scan range  m/z 200‐1050  Signal threshold  1e4 














    ‐Toco  SD  r2  ‐Toco  SD  r2  ‐Toco  SD  r2 
Cherry  UV  217  22  0.9765 636  14  0.9662 151  10  0.9893
Parinari  UV  5427a  104    616  31         
Soybean  UV        193  19    205  12   
  External Standard Method 
    ‐Toco  SD  r2  ‐Toco  SD  r2  ‐Toco  SD  r2 
Cherry  UV  217  22  0.9765 717  17  0.9738 118  13  0.9947
  SIM  278  18  0.9898 583  13  0.9766 98.0  5.1  0.9762
  SRM  244  21  0.9328 717  40  0.9459 126  10  0.9324
Parinari  UV  5427a  104    688  39         
  SIM  643.3  1.6    705  27         
  SRM  631  95    849  127         
Soybean  UV        168  24    186  15   
  SIM  30.8  1.8    150.8  4.3    213  11   







    ‐Toco (ppm)  ‐Toco (ppm)  ‐Toco (ppm) 
LODa  UV  200  15  44 
b+3*0.125  SIM  7.5  79  99 
  SRM  6.5  42  23 
LOQb  UV  668  51  146 
b+10*0.125  SIM  25  264  330 
  SRM  22  139  76 
  External Standard Method 
    ‐Toco (ppm)  ‐Toco (ppm)  ‐Toco (ppm) 
LODa  UV  200  36  71 
b+3*0.125  SIM  25  59  81 
  SRM  20  39  13 
LOQb  UV  668  120  235 
b+10*0.125  SIM  82  196  271 









































  APPI‐MS  SD  GC‐FID   
M (14:0)  0.000%  0.000%  0.033%   
Po (16:1)  0.020%  0.001%  0.018%   
P (16:0)  9.136%  0.042%  9.287%  GC‐FID  SD 
El  
(all 18:3) 
48.768%  0.096%  48.840%  ‐El  90.00%  0.07% 
L (18:2)  14.379%  0.137%  13.992%  ‐El  7.63%  0.06% 
O (18:1)  17.709%  0.060%  17.518%  Ln  0.09%  0.00% 
S (18:0)  7.267%  0.113%  7.589%  18:3x1  1.70%  0.04% 
A (20:0)  0.402%  0.006%  0.395%  18:3x2  0.38%  0.01% 
G (20:1)  0.688%  0.014%  0.695%  18:3x3  0.14%  0.01% 
21:0  0.003%  0.000%  0.000%  18:3x4  0.06%  0.01% 
B (22:0)  0.031%  0.000%  0.032%  100.00%   
23:0  0.005%  0.000%  0.014%  GC‐FID  SD 
Lg (24:0)  0.022%  0.001%  0.033%  oxo‐El‐1  3.60%  0.49% 
25:0  0.004%  0.000%  0.012%  oxo‐El‐2  81.01%  0.76% 
Ce (26:0)  0.003%  0.000%  0.000%  oxo‐El‐3  2.07%  0.34% 
oxo‐El  1.563%  0.017%  1.543%  oxo‐El‐4  13.32%  0.30% 









FA  APCI‐MS  SD  GC‐FID 
M  0.006%  0.000%  0.069% 
Po  0.629%  0.030%  0.626% 
P  8.841%  0.120%  8.324% 
El  5.766%  0.115%  5.760% 
L  32.650%  0.243%  33.320% 
O  47.825%  0.203%  47.598% 
S  2.437%  0.011%  2.507% 
A  0.943%  0.008%  0.916% 
G  0.423%  0.002%  0.405% 
21  0.015%  0.001%  0.015% 
B  0.208%  0.001%  0.202% 
23  0.025%  0.001%  0.031% 
Lg  0.193%  0.006%  0.187% 
25  0.017%  0.001%  0.022% 
Ce  0.022%  0.001%  0.018% 







FA  APCI‐MS  SD  GC‐FID 
M  0.002%  0.000%  0.094% 
Po  0.098%  0.009%  0.102% 
P  12.109%  0.064%  11.953% 
Ln  7.406%  0.103%  7.519% 
L  52.699%  0.474%  51.515% 
O  22.369%  0.189%  23.619% 
S  4.286%  0.113%  4.175% 
A  0.336%  0.008%  0.323% 
G  0.197%  0.005%  0.184% 
21  0.023%  0.000%  0.021% 
B  0.341%  0.012%  0.329% 
23  0.016%  0.000%  0.032% 
Lg  0.106%  0.005%  0.102% 
25  0.005%  0.000%  0.008% 
Ce  0.007%  0.001%  0.021% 





















DAG  % Comp.  SD  2/1 
ElEl  0.03%  0.01%  0.62 
LEl  1.11%  0.07%  0.66 
LL  18.14%  0.56%  0.47 
OEl  0.54%  0.02%  0.54 
PoO  0.19%  0.04%  0.64 
PoP  0.57%  0.10%  0.54 
OL  28.72%  1.62%  0.35 
PL  12.06%  1.06%  0.23 
OO  22.40%  1.14%  0.28 
OP  11.38%  0.13%  0.28 
SL  2.98%  0.09%  0.29 








DAG  % Comp.  SD  2/1 
LnLn  0.49%  0.07%  0.34 
LLn  7.29%  0.19%  0.54 
LL  43.73%  1.39%  0.56 
OLn  1.02%  0.18%  0.40 
PoO  0.00%  0.00%    
PoP  0.03%  0.01%  0.71 
OL  15.84%  1.20%  0.39 
PL  15.78%  0.37%  0.20 
OO  4.90%  0.22%  0.26 
OP  3.93%  0.07%  0.29 
SL  5.33%  0.10%  0.27 








DAG  % Comp.  SD  2/1 
oxEloxEl  0.02%  0.00%    
oxEoEo  0.75%  0.07%  0.21 
oxEoL  0.10%  0.01%  0.28 
oxEoO  0.17%  0.01%  0.23 
oxEoP  0.10%  0.01%  0.30 
ElEl  17.91%  0.62%  2.57 
LEl  11.25%  0.10%  2.72 
LL  11.49%  0.10%  4.19 
OEl  12.60%  0.30%  1.57 
PoO  0.75%  0.03%  1.61 
PoP  0.06%  0.01%  1.37 
OL  14.53%  0.45%  3.43 
PL  6.73%  0.10%  1.53 
OO  6.87%  0.17%  1.50 
OP  6.91%  0.11%  0.72 
SL  4.72%  0.17%  1.59 











TAG  RT  % Comp.  SD  TAG  RT  % Comp.  SD 
ElElEl  55.10  0.017%  0.001%  LOA  94.47  0.880%  0.021% 
ElElL  56.80  0.634%  0.012%  LLB  94.98  0.153%  0.002% 
LLEl  58.46  5.377%  0.066%  POS  95.97  0.380%  0.003% 
LLL  60.33  3.964%  0.025%  PLA  96.46  0.218%  0.009% 
ElElO  62.14  0.211%  0.008%  SSL  96.54  0.112%  0.003% 
ElElP  63.32  0.040%  0.003%  OL‐21  98.76  0.019%  0.001% 
OLEl  64.22  4.258%  0.275%  LL‐23  99.18  0.024%  0.000% 
PLEl  65.50  2.044%  0.084%  PPS  99.76  0.001%  0.000% 
LLO  66.35  13.434%  0.372%  LElLg  100.66  0.010%  0.000% 
PoPL  67.27  0.902%  0.110%  SOG  101.77  0.018%  0.005% 
LLP  67.76  3.506%  0.044%  OOA  102.36  0.755%  0.015% 
ElElG  68.73  0.002%  0.000%  OLB  102.64  0.178%  0.003% 
MOL  69.53  0.019%  0.001%  LLLg  102.95  0.140%  0.003% 
EoEoS  71.12  0.028%  0.002%  POA  104.27  0.202%  0.001% 
OOEl  71.12  2.090%  0.017%  SSO  104.37  0.130%  0.002% 
POEl  72.73  0.614%  0.009%  PBL  104.42  0.058%  0.001% 
OOL  73.73  16.632%  0.332%  SLA  104.68  0.060%  0.002% 
LLG  73.86  0.318%  0.016%  OO‐21  105.87  0.012%  0.002% 
POPo  74.81  0.992%  0.117%  OL‐23  106.04  0.028%  0.001% 
POL  75.42  7.442%  0.144%  LL‐25  106.25  0.016%  0.001% 
LLS  76.40  0.774%  0.018%  OOB  108.92  0.148%  0.005% 
PPL  77.30  0.597%  0.012%  OLLg  109.10  0.167%  0.003% 
LElA  79.60  0.027%  0.001%  LLCe  109.28  0.017%  0.000% 
ElElA  80.13  0.002%  0.000%  PLLg  110.63  0.052%  0.004% 
SOEl  82.46  0.989%  0.033%  POB  110.65  0.046%  0.002% 
OOO  82.51  17.235%  0.247%  SLB  110.83  0.020%  0.001% 
OLG  82.59  0.477%  0.004%  SOA  110.89  0.057%  0.004% 
OOP  84.44  6.991%  0.153%  OO‐23  111.81  0.023%  0.001% 
PLG  84.54  0.193%  0.015%  OL‐25  111.95  0.018%  0.000% 
SLO  85.28  1.695%  0.011%  OOLg  114.76  0.152%  0.009% 
LLA  86.08  0.622%  0.009%  OLCe  114.83  0.020%  0.002% 
POP  86.51  0.606%  0.001%  PLCe  116.40  0.005%  0.000% 
SLP  87.36  0.309%  0.003%  POLg  116.42  0.042%  0.002% 
PPP  89.98  0.001%  0.000%  SLLg  116.79  0.009%  0.001% 
LL‐21  90.60  0.016%  0.001%  SOB  116.82  0.011%  0.002% 
OOG  91.14  0.270%  0.002%  OO‐25  117.64  0.016%  0.002% 
ElOA  91.70  0.027%  0.003%  OOCe  120.56  0.018%  0.001% 
LElB  92.27  0.012%  0.000%  POCe  122.44  0.006%  0.002% 
OOS  93.82  2.332%  0.005%  SOLg  122.79  0.011%  0.001% 
EoSS  93.98  0.066%  0.020%  OOMo  126.67  0.001%  0.000% 






TAG  RT  % Comp.  SD TAG RT % Comp.  SD 
oxEloxEloxEl  32.02  0.000%  0.000% ElEl‐21 84.80 0.008%  0.000%
oxEloxElEl  40.28  0.030%  0.001% SLO 85.04 1.392%  0.062%
oxEloxElL  41.35  0.005%  0.000% LLA 85.83 0.026%  0.001%
oxEloxElO  43.58  0.011%  0.000% POP 86.29 0.528%  0.018%
oxEloxElP  43.91  0.011%  0.001% SLP 87.09 0.930%  0.026%
oxElElEl  46.02  1.269%  0.019% ElElB 89.30 0.032%  0.001%
oxElElL  47.08  0.384%  0.009% PPP 89.64 0.022%  0.000%
oxEloxElS  47.38  0.013%  0.000% OOG 90.98 0.071%  0.001%
oxElLL  48.20  0.034%  0.002% ElOA 91.46 0.122%  0.010%
oxElElO  50.54  0.865%  0.006% LElB 92.04 0.010%  0.000%
oxElElP  51.23  0.676%  0.022% ElEl‐23 93.65 0.011%  0.000%
oxElLO  51.87  0.085%  0.001% OOS 93.68 0.845%  0.026%
oxElLP  52.56  0.043%  0.001% ElSS 93.83 0.934%  0.023%
oxElOO  56.21  0.143%  0.004% LLB 94.84 0.003%  0.000%
oxElElS  56.26  0.850%  0.018% POS 95.79 0.747%  0.009%
oxElOP  56.83  0.058%  0.000% PLA 96.36 0.136%  0.001%
oxElPP  57.75  0.008%  0.000% SSL 96.38 0.400%  0.012%
oxElLS  57.85  0.047%  0.003% ElElLg 97.90 0.028%  0.001%
oxElOS  63.36  0.060%  0.004% OL‐21 98.41 0.001%  0.000%
oxElSP  64.23  0.038%  0.001% LL‐23 98.96 0.001%  0.000%
oxElSS  72.40  0.019%  0.002% PPS 99.31 0.051%  0.001%
ElElEl  55.11  12.036%  0.191% LElLg 100.40 0.009%  0.000%
ElElL  56.70  8.252%  0.143% SOG 101.83 0.043%  0.007%
LLEl  58.47  3.348%  0.092% ElEl‐25 101.83 0.008%  0.000%
LLL  60.31  0.405%  0.013% OOA 102.10 0.030%  0.002%
ElElO  62.05  11.267%  0.153% OLB 102.46 0.015%  0.001%
ElElP  63.23  8.090%  0.141% LLLg 102.80 0.003%  0.000%
OLEl  64.10  7.790%  0.254% POA 104.09 0.091%  0.002%
PLEl  65.44  4.556%  0.134% SSO 104.19 0.339%  0.009%
LLO  66.33  1.018%  0.020% PBL 104.37 0.012%  0.000%
PoPL  66.95  0.008%  0.001% SLA 104.45 0.034%  0.001%
LLP  67.64  0.863%  0.024% ElElCe 105.19 0.006%  0.000%
ElElG  68.65  1.274%  0.038% OL‐23 105.83 0.002%  0.000%
ElElS  70.83  8.941%  0.531% OOB 108.76 0.004%  0.000%
OOEl  70.94  4.202%  0.118% OLLg 108.88 0.008%  0.001%
POEl  72.50  3.003%  0.084% PLLg 110.44 0.006%  0.000%
LLG  73.27  0.185%  0.042% SLB 110.51 0.006%  0.001%
OOL  73.53  1.782%  0.048% SOA 110.62 0.028%  0.001%
PPEl  74.35  0.429%  0.014% POB 110.66 0.008%  0.000%
POPo  74.40  0.041%  0.002% OO‐23 111.52 0.002%  0.000%
POL  75.30  2.094%  0.033% OL‐25 111.75 0.002%  0.000%
LLS  76.15  0.484%  0.012% OOLg 114.56 0.005%  0.000%
PPL  77.15  0.701%  0.012% OLCe 114.71 0.002%  0.000%
LElA  79.48  0.277%  0.001% POLg 116.16 0.003%  0.001%
ElElA  79.89  0.474%  0.010% PLCe 116.35 0.001%  0.000%
SOEl  82.19  2.995%  0.100% SOB 116.54 0.003%  0.000%
OOO  82.21  0.961%  0.018% SLLg 116.57 0.003%  0.000%
OLG  82.29  0.342%  0.051% OO‐25 117.51 0.001%  0.000%
OOP  84.24  1.413%  0.030% POCe 122.29 0.002%  0.001%
ElSP  84.32  0.974%  0.059% SOLg 122.81 0.004%  0.002%








TAG  RT  % Comp.  SD  TAG  RT  % Comp.  SD 
LnLnLn  49.69  0.068%  0.002%  LLB  95.03  0.319%  0.004% 
LnLnL  52.73  0.919%  0.012%  POS  95.97  0.560%  0.009% 
LLLn  56.28  6.383%  0.026%  PLA  96.53  0.239%  0.007% 
LnLnO  57.15  0.537%  0.118%  SSL  96.63  0.463%  0.017% 
LnLnP  58.18  0.207%  0.007%  LLnLg  96.94  0.028%  0.001% 
LLL  60.32  16.528%  0.303%  OL‐21  98.69  0.022%  0.000% 
OLLn  61.32  4.870%  0.130%  LL‐23  99.14  0.027%  0.001% 
PLLn  62.55  3.175%  0.097%  PPS  99.59  0.009%  0.000% 
LLO  66.38  14.021%  0.518%  OOA  102.25  0.071%  0.004% 
PoPL  66.99  0.009%  0.002%  OLB  102.68  0.183%  0.010% 
OOLn  67.70  2.337%  0.017%  LLLg  102.91  0.093%  0.005% 
LLP  67.75  12.466%  0.073%  SSO  104.28  0.165%  0.011% 
PoOL  68.88  0.247%  0.022%  POA  104.32  0.092%  0.006% 
POLn  68.95  1.274%  0.098%  PBL  104.38  0.181%  0.008% 
PPLn  70.72  0.140%  0.008%  SLA  104.55  0.104%  0.005% 
OOL  73.79  5.986%  0.094%  OO‐21  105.81  0.008%  0.001% 
LLG  73.89  0.262%  0.010%  OL‐23  106.05  0.015%  0.000% 
POPo  74.86  0.039%  0.006%  LL‐25  106.37  0.008%  0.000% 
POL  75.45  7.306%  0.040%  OOB  108.90  0.096%  0.005% 
LLS  76.37  4.198%  0.048%  OLLg  109.08  0.057%  0.002% 
PPL  77.28  2.301%  0.041%  LLCe  109.18  0.007%  0.001% 
SOLn  77.91  0.409%  0.015%  POB  110.57  0.055%  0.003% 
LLnA  78.93  0.057%  0.005%  PLLg  110.69  0.072%  0.003% 
OOO  82.51  2.809%  0.131%  SOA  110.81  0.031%  0.002% 
OLG  82.59  0.151%  0.004%  SLB  110.90  0.080%  0.004% 
PLG  84.47  0.131%  0.020%  OO‐23  111.80  0.006%  0.001% 
OOP  84.47  2.620%  0.100%  OL‐25  111.99  0.005%  0.000% 
SLO  85.33  3.370%  0.198%  OOLg  114.74  0.031%  0.001% 
LLA  86.07  0.247%  0.013%  OLCe  114.79  0.005%  0.001% 
POP  86.45  0.641%  0.041%  POLg  116.40  0.015%  0.003% 
SLP  87.37  1.736%  0.054%  PLCe  116.41  0.004%  0.000% 
LLnB  88.32  0.091%  0.005%  SLLg  116.78  0.018%  0.001% 
MOS  89.92  0.006%  0.001%  SOB  116.86  0.026%  0.002% 
PPP  89.92  0.008%  0.000%  OO‐25  117.68  0.002%  0.000% 
LL‐21  90.61  0.038%  0.001%  OOCe  120.50  0.002%  0.000% 
OOG  91.23  0.054%  0.003%  POCe  122.58  0.001%  0.000% 
OOS  93.80  1.068%  0.041%  SLCe  122.66  0.001%  0.000% 
LOA  94.54  0.177%  0.007%  SOLg  122.86  0.007%  0.000% 
       Sum  100.000% 
 
S‐19 
 
9. 2D UHPLC Plots for cherry pit oil. 
 
Figure S‐4. 2D UHPLC contour plot of cherry pit oil by APPI‐MS on TSQ Quantum Access Max. 
 
Figure S‐5. 2D UHPLC contour plot of cherry pit oil by ESI‐MS on LCQ Deca XP. 
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10. 2D UHPLC Plots for soybean oil. 
 
Figure S‐6. 2D UHPLC contour plot of soybean oil by APPI‐MS on TSQ Quantum Access Max. 
 
Figure S‐7. 2D UHPLC contour plot of soybean oil by ESI‐MS on LCQ Deca XP. 
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Figures S‐6 and S‐7 show that TAGs with few degrees of unsaturation could be forced to be retained 
on the column longer by using a sharper reverse gradient, shown in Figure S‐3. Notice the elution time 
of OLO in Figures S‐6 and S‐7 compared to OOL in Figures S‐4 and S‐5. However, LLLn and LLO 
experienced “wraparound” by eluting in the next modulation period, due to the lower ACN composition. 
Therefore, we have increased the ACN percentage to be intermediate between the gradient used for 
eleostearic acid‐containing oils and this gradient. But we show these data to demonstrate the control 
that fine‐tuning the ACN composition allows and because the quantification of the FSV and TAGs from 
the 1D was unaffected.   
The TAG identities are given by the masses of the [M+NH4]+ ions in ESI‐MS spectra, and by [M+H]+ 
and [DAG]+ fragments in APPI‐MS spectra. As we reported previously, the [DAG]+ fragment ratios in ESI‐
MS and APPI‐MS mass spectra are not as consistent for regioisomer identification as APCI‐MS mass 
spectra.8 Therefore, regioisomers identities for SBO were taken from our earlier report of SBO isomers7 
and were inferred from elution characteristics in the 2D UHPLC chromatograms, not solely from [DAG]+ 
ratios. APPI‐MS has the distinct advantage that it is a non‐contact ionization mode, unlike APCI‐MS that 
accumulates a ‘glob’ of residue on the corona needle after extended exposure to solvents containing 
acetonitrile. But the [DAG]+ fragment ratios are not as directly correlated with the regioisomeric 
positions of FAs in TAGs as in APCI‐MS spectra. Thus, there is a trade‐off in the use of APPI‐MS versus 
APCI‐MS. 
The soybean oil analyzed for these experiments was a Halal SBO ordered from an online supplier, 
and showed higher levels of 18:3 isomers by GC‐FID and GC‐MS than most SBOs we have analyzed in the 
past, as well as some early‐eluting TAG oxidation products (TAGOX). Normal linolenic acid represented 
63.9% of all 18:3 species by GC‐FID, another isomer was 15.8%, a third was 15.0%, and a fourth was 
5.4%. Linoleic acid also showed isomers, with normal linoleic acid being 96.0% by GC‐FID, one isomer 
being 2.1% and another being 1.9%. Two isomers of 18:1 were present, with oleic acid being 94.2% and 
the second isomer being 5.8%. Thus, Figures S‐6 and S‐7 show some of the minor TAG peaks labelled 
with “iso” to indicate additional isomer peaks. The combination of oxidation products and isomers may 
indicate that the oil was not stored properly prior to sale, or may indicate sample production or 
processing issues. Based on the current status of literature precedent, the ESI‐MS and APPI‐MS mass 
spectra were not sufficiently definitive to allow localization of the double bond positions. Of course, 
with adequate standards, the 2D‐LC retention times could be used to identify the isomers, since, in 
many cases, they were separated on the new Ag‐Ion UHPLC column. Since individual double bond 
isomers have not been specifically identified, the results for SBO FAs, DAGs, and TAGs in Tables S‐17, S‐
20, and S‐23, respectively, represent the sum of all isomers for each FA. 
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